论文部分内容阅读
目的:研究艾迪注射液对放射治疗非小细胞肺癌疗效和放疗副作用的影响。方法:64例病理确诊的非小细胞肺癌患者随机分组为两组:放疗加艾迪注射液组(治疗组)33例,单纯放疗组(对照组)31例,放疗采用常规外放疗,艾迪注射液60~100mL每日静脉滴注,比较两组间效果。结果:治疗组治疗有效率72.7%,对照组治疗有效率48.4%,两组比较P<0.05,有显著性差异;两组之间体重稳定情况比较、白细胞有否降低情况比较、乏力减轻情况比较、卡氏评分比较均显示P<0.05,有显著性差异。治疗组T淋巴细胞亚群CD3+、CD4+、CD4+/CD8+与治疗前比较无明显降低,而对照组则相反。结论:艾迪注射液应用于放射治疗晚期肺癌中可以提高近期疗效,减轻放疗副作用,提高患者免疫力,改善患者生活质量。
Objective: To study the effects of Aidi Injection on the efficacy and side effects of radiotherapy for non-small cell lung cancer. Methods: Sixty-four patients with pathologically confirmed non-small cell lung cancer were randomly divided into two groups: 33 in radiotherapy plus Aidi injection group (treatment group), 31 in radiotherapy alone group (control group) Injection 60 ~ 100mL daily intravenous drip, the effect between the two groups were compared. Results: The treatment group, the effective rate of 72.7%, the control group, the effective rate of 48.4%, the two groups were compared P <0.05, significant differences between the two groups were compared weight stability, white blood cells were reduced compared to reduce fatigue compared , Karnofsky scores showed P <0.05, there are significant differences. The T lymphocyte subsets CD3 +, CD4 +, CD4 + / CD8 + in the treatment group were not significantly lower than those before treatment, but the control group was the opposite. Conclusion: Aidi injection for advanced lung cancer in radiotherapy can improve the short-term curative effect, reduce side effects of radiotherapy, improve patient’s immunity and improve the quality of life of patients.